Cancer Clinical Trial - HHRI NABPLAGEM-NEO 2017-001

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT03138720

CONDITION(S): Pancreatic - TRIAL: HHRI NABPLAGEM-NEO 2017-001 - Pre-operative Treatment for Patients With Untreated Pancreatic Cancer.

The purpose of this study is to determine if the combination of paclitaxel protein bound, gemcitabine, cisplatin, paricalcitol are effective in individuals with resectable and unresectable pancreatic cancer.

Drug

Paclitaxel Protein Bound (Abraxane)

Trial Type

Interventional

Age Range

18 years or older

Phase

Phase 2

Condition

Pancreatic cancer

Keywords

Pancreatic cancer